TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

21.10$ +13.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 287 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OMER
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
493 378 437 356 313 277 235 201 186 326 286 287
351 218 281 203 165 134 96 70 72 216 180 185
31 7.1 1.8 2.1 1.5 3.4 4.3 1.9 2.4 9.7 1.9 2.0
310 230 159 123 90 52 29 36 172 135 132
36 6.7 37 38 36 37 5.6 34 32 36 38 21
0.2 0.8
507 403 509 481 468 460 449 429 406 447 350 338
147 53 59 59 56 80 83 86 81 78 59 95
100 24 25 5.8 27 54 23 23 23 26 38
5.9 7.7 6.2 6.5 7.7 5.9 4.4 8.8 12 4.8 5.4 6.3
222 213 213 191 189 167 159 151 160 209 137 97
-14 -25 -71 -125 -154 -183 -214 -229 -220 -121 -63 -51
-744 -754 -791 -847 -879 -910 -944 -969 -1,000 -914 -858 -844
63 61 59 58 58 58 58 59 66 64 90 90

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?